CAU Scholar's Space: Chang, In Ho

Detailed Information

Chang, In Ho (장인호)

의과대학 (의학부(임상-서울))

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Bladder cancer:13||Urinary bladder neoplasms:11||Prostatic neoplasms:7||Immunotherapy:6||Cancer:6||mTOR:5||Prostate cancer:5||obesity:4||Prostatic hyperplasia:4||Recurrence:4||Bladder:4||Urolithiasis:4||Urinary bladder:3||Benign prostatic hyperplasia:3||Urinary tract infections:3||Bacillus CalmetteGuérin:3||Bioprinting:3||BCG:3||autophagy:3||Korea:3||bladder cancer:3||body mass index:3||Antibodydrug conjugate:3||Chemotherapy:3||Poloxamer 407:3||Antimicrobial peptide:3||urolithiasis:3||Temperature:2||Prognosis:2||Urinary Bladder Neoplasms:2||Bone neoplasms:2||Floating hydrogel:2||Intravesical instillation:2||Organonachip:2||Immune checkpoint inhibitors:2||Overactive bladder:2||Kidney:2||Microenviroment:2||Progression:2||BCG vaccine:2||Drug therapy:2||Prostate:2||prostate cancer:2||Cell wall skeleton:2||bladder:2||Tolllike receptors:2||Mouse Orthotopic Model:2||rapamycin:2||Tomography:2||renal colic:2||Combination therapy:2||Survival:2||Multidetector computed tomography:2||cancer:2||Laparoscopy:2||Body mass index:2||Prostatitis:2||3D bioprinting:2||Prostatespecific antigen:2||Population:2||Bacillus Calmette–Guérin:2||Biomarker:2||Neoplasm metastasis:2||Gemcitabine:2||insulin resistance:2||hemodilution:2||Renal cell carcinoma:2||Urothelial carcinoma:2||Resistin:2||Vascularization:2||mitochondrial biogenesis:2||Artificial intelligence:2||Hernia:1||Human:1||Humidity:1||Hyaluronic acid:1||Hydrogen peroxide:1||Immune cells:1||Immune response:1||Immunoconjugates:1||In vivo imaging system:1||Incidental:1||Injuries:1||Interleukin1beta:1||Interleukin6:1||Internalization:1||Interrupted Time Series Analysis:1||Intravesical administration:1||Intravesical delivery:1||Intravesical treatment:1||Kidney calculi:1||Knowledgebased iterative reconstruction:1||Korean:1||Labonachip:1||Leptin:1||Ligand:1||Liposome:1||Liquid biopsy:1||Lithotripsy:1||Lowdose:1||Lowdose computed tomography:1||Lower urinary tract symptoms:1||MEK inhibitors:1||Magnetic resonance imaging:1||Magnetic resonance spectroscopy:1||Mass screening:1||Mechanosensor:1||Medical therapy:1||Melatonin:1||Menopause:1||Metabolic syndrome X:1||Metastatic renal cell carcinoma:1||Microarray:1||Microarray analysis:1||Microbiome:1||Microfluidics:1||Modelbased iterative reconstruction:1||Molecular biology:1||Mortality:1||Mtor protein:1||Multiple renal masses:1||Murine betadefensin2:1||Muscarinic M2 receptor:1||Muscarinic M3 receptor:1||Mycobacterium bovis:1||NBR1:1||NFkappa B activation:1||Nanoparticle:1||Necrosis:1||Nectin4:1||Neoplasm invasion:1||Nephrolithiasis:1||Network metaanalysis:1||Nitric oxide synthase type I:1||Nocturia:1||Nonmuscle invasive bladder cancer (NMIBC):1||Obesity:1||Oncocytoma, renal:1||Oncocytosis, renal:1||Oncolytic virotherapy:1||Organoid:1||Overall survival:1||Overweight:1||PD1:1||PLGA:1||Pain:1||Pediatric urolithiasis:1||Pelvic bones:1||Penis:1||Perfusion imaging:1||Peroxiredoxin I.:1||Piezo1:1||Pneumothorax:1||Polymorphism:1||Prognostic markers:1||Prostate biopsy:1||Pyelonephritis:1||Quinolone resistance:1||Radiation:1||Radiation dosage:1||Radiation therapy:1||Radical prostatectomy:1||Rapamycin:1||Reactive oxygen species:1||Recombinant:1||Risk Factors:1||Risk factor:1||Risk factors:1||S100A2 protein:1||S100A4 protein:1||S6K1:1||Scoring method:1||Scrotum:1||Smooth muscles:1||Spiral computed:1||Src:1||Statistical iterative reconstruction:1||Stress urinary incontinence:1||Suburethral slings:1||Superficial angiomyxoma:1||Surgical intervention:1||Surveillance:1||Survival rate:1||Synovial sarcoma:1||Systematic review:1||TLR4:1||Target therapy:1||Targeted delivery:1||Telomerase reverse transcriptase:1||Thermosensitive hydrogel:1||Thrombus:1||TimeSeries Analysis:1||Tissue:1||Transitional cell:1||Transurethral Resection of Prostate:1||Treatment outcome:1||Triplet therapy:1||Tumor biomarker:1||Tumor microenvironment:1||Ultrasonography:1||Ureteral neoplasms:1||Ureteral stump:1||Urinary Tract Infections:1||Urinary calculi:1||Urinary tract infection:1||Urine:1||Urokinase:1||Urological cancer:1||Urology:1||Uromodulin:1||Vagina:1||Warfarin:1||Xray computed:1||YAP:1||age:1||akt:1||aldosterone:1||alpha blockers:1||alphafetoprotein:1||antimicrobial peptides (AMPs):1||antitumor efficacy:1||apparent diffusion coefficient value:1||bacillus CalmetteGuerin:1||bacillus CalmetteGuerin (BCG):1||benign prostatic hyperplasia:1||biological:1||bladder cancer cells:1||bone:1||bone marrow:1||cMet and hepatocyte growth factor:1||cancer risk:1||cancerassociated antigen 125:1||carbohydrate antigen 199:1||carcinoembryonic antigen:1||chronic renal disease:1||comorbidity:1||computed tomography:1||deep learning:1||diphtheria toxoid:1||eIF4E:1||emergency department:1||endoplasmic reticulum (ER) stress:1||enhanced uptake:1||erectile dysfunction:1||gemcitabine:1||healthcare:1||hepsin:1||human:1||human betadefensin 2:1||human betadefensin2:1||hyaluronic acid:1||hydrogel:1||immune cell:1||immune checkpoint:1||immunization:1||immunohistochemistry:1||intracavernosal injection:1||intravesical:1||intravesical instillation.:1||juxtaglomerular tumor:1||language model:1||lipopolysaccharide:1||lower urinary tract symptom:1||mTOR signaling:1||metabolic syndrome:1||metabolic syndrome X:1||metastasis:1||microenvironment:1||multiparametric magnetic resonance imaging:1||neoplasm:1||nonenhanced computed tomography:1||orthotopic bladder cancer mouse model:1||osteoblasts:1||osteoclasts:1||p70S6K:1||patient knowledge:1||phantoms, imaging:1||poloxamer 407:1||polymorphism:1||prognostic indicator:1||programmed cell deathligand 1:1||prolonged retention:1||prostate:1||prostatespecific antigen:1||prostatic neoplasms:1||radiation dosage:1||radiation dose:1||reactive oxygen species (ROS):1||renin:1||reninproducing tumor:1||reninoma:1||resistin:1||robotassisted partial nephrectomy:1||signs and symptoms:1||sildenafil:1||singleshot vaccine:1||stearic acid:1||tamsulosin:1||testosterone:1||therapeutics:1||tolllike receptors 2 and 4 (TLR2 and TLR4):1||tomography, Xray computed:1||tumor markers:1||tumor suppressor serine/threonine kinase 11 (LKB1):1||ureterolithiasis:1||urinary bladder:1||urinary tract:1||urothelial carcinoma:1||urothelial carcinoma (URCa):1||AMP activated protein kinase (AMPK):1||AMPK:1||Abscess:1||Acetylcholine:1||Adiponectin:1||Adjuvant immunotherapy:1||Administration:1||Adverse effects:1||Aggressive angiomyxoma:1||Alphablocker:1||Angiomyolipoma:1||Antimicrobial drug resistance:1||BCGCWS drugdelivery system:1||Bacillus:1||Bacillus Calmette–Guérin (BCG):1||Bacillus CalmetteGuerin:1||Bacteria:1||Bacterial sexually transmitted diseases:1||Benign Prostatic Hyperplasia:1||Beta defensin 3:1||Biomarkers:1||Biomaterials:1||Bladder Cancer:1||Bladder outlet obstruction:1||Bladder simulation model:1||Body mass index percentile:1||BoxBehnken design:1||Calcium sensing receptor:1||CalmetteGuerin:1||Cancer risk:1||Canceronachip:1||Capnothorax:1||Carcinoma:1||Carcinoma, renal cell:1||Castrationsensitive:1||Catastrophization:1||Cellpenetrating peptide:1||Central composite design:1||Chromophobe renal cell carcinoma:1||Computerassisted image processing:1||Cystoscopy:1||Cytokine therapy:1||Cytokines:1||Cytology:1||Cytoreductive nephrectomy:1||Defensins:1||Delayed diagnosis:1||Depression:1||Drug delivery system:1||Drug resistance:1||Drug screening:1||EORTC:1||Early detection of cancer:1||Engineering:1||Erectile dysfunction:1||Filtered back projection:1||Fluid shear stress:1||Folate:1||Fosfomycin:1||Gender identity:1||Genes, myc:1||Genetic polymorphism:1||Genetic recombination:1||Genetically:1||Glomerular filtration rate:1||Growth:1||HBD3:1||HER2:1||Hematuria:1||Hemorrhage:1||Heparin:1||

STATISTICS: Total View :6,842,455; Today View :2,201

RSS_1.0 RSS_2.0 ATOM_1.0

84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE